viewDirecta Plus PLC

Directa Plus PLC - Grant of US Patent

RNS Number : 5527D
Directa Plus PLC
27 June 2019

27 June  2019


Directa Plus plc

("Directa Plus" or the "Company")


US Patent Grant


Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce the grant of a key patent, relating to the Company's unique manufacturing process, by the United States Patent and Trademark Office.


The new US patent covers Directa Plus' unique process for manufacturing graphene nanoplatelets using a water-based exfoliation technology.  The process is sustainable and environmentally friendly as a result of using no chemicals, solvents or surfactants and generating zero waste.  The manufacturing process allows the Company to engineer a wide range of particle morphologies that can be tailored to the particular requirements of end-user customers.  In addition, the 100 per cent production yield means that Directa Plus can manufacture products in large volumes at attractive prices.  This provides a significant competitive advantage, enabling the Company to integrate effectively and quickly with customers' large supply chains.


Commenting on the grant, Giulio Cesareo, Founder and CEO of Directa Plus, said: "This grant represents a key development in launching our products into the United States.  The sustainable nature of our production process, using no chemicals, is proving to be an attractive point of difference in negotiations with large US companies."


For further information please visit http://www.directa-plus.com/ or contact:


Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO


Marco Ferrari, CFO




Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies Will Goode (Corporate Finance)


Caspar Shand Kydd (Sales)




N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle




Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Barnaby Hayward, Edward Lee



About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products).  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products.  All our products are hypoallergenic, non-toxic and sustainably produced.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Directa Plus PLC

Price: 80

Market: AIM
Market Cap: £48.8 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Directa Plus to add graphene enhancement G+ to range of jeans

Giulio Cesareo, chief executive of Directa Plus Plc (LON:DCTA), tells Proactive Investors they're to add their graphene enhancement G+ to a range of jeans made by Arvind - one of India’s top textile groups. Arvind makes six million pairs of jeans every year using 100mln metres of fabric...

on 15/5/18